BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4720439)

  • 1. [Acromegaly. 3. Significance of the dynamic study of somatotropin].
    Marek J; Srámková J; Bleha O; Engelberth O
    Cas Lek Cesk; 1973; 112(28):849-53. PubMed ID: 4720439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the neuroendocrine control of somatotropin secretion in acromegaly].
    Bracaccia M; Angeletti G; Duranti G; Brenari P; Caraceni L; Santeusanio F
    Recenti Prog Med; 1987 Dec; 78(12):535-8. PubMed ID: 3451307
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of oral glucose tolerance in the diagnosis of acromegaly].
    von Werder K; Bottermann P; Hartmann P; Schwarz K
    Med Klin; 1972 Oct; 67(43):1398-401. PubMed ID: 4641922
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of some radioimmunological methods for determination of somatotropin in human plasma (with reference to sex and acromegaly)].
    Nedvídková J; Felt V
    Vnitr Lek; 1973 Feb; 19(2):142-50. PubMed ID: 4687812
    [No Abstract]   [Full Text] [Related]  

  • 5. [Somatotrophic response to hypoglycemic stimulus in patients with acromegaly. Effect of bromocriptine].
    Fiszlejder L; Bokser L; Puyo AM; Chervin AB; Guitelman A
    Medicina (B Aires); 1986; 46(1):16-24. PubMed ID: 3543606
    [No Abstract]   [Full Text] [Related]  

  • 6. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies of hypothalamic control of somatotropin incretion in acromegaly].
    Liuzzi A; Chiodini PG; Botalla L; Cremascoli G; Tosi M
    Folia Endocrinol; 1973 Dec; 26(6):503-9. PubMed ID: 4801261
    [No Abstract]   [Full Text] [Related]  

  • 8. Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
    Wass JA
    J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acromegaly].
    Zapf J
    Schweiz Rundsch Med Prax; 1984 Mar; 73(10):293-8. PubMed ID: 6709989
    [No Abstract]   [Full Text] [Related]  

  • 10. Acromegaly with 'normal' growth hormone levels.
    Feingold KR; Lorenz TJ
    West J Med; 1985 Jan; 142(1):95-7. PubMed ID: 3976225
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test.
    Mazziotti G; Bonadonna S; Doga M; Patelli I; Gazzaruso C; Solerte SB; De Menis E; Giustina A
    Neuroendocrinology; 2008; 88(4):299-304. PubMed ID: 18617732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thyroliberin (TRH), bromocriptine and cyproheptadine on somatotropin secretion in acromegaly.
    Pawlikowski M; Strejczek H; Owczarczyk I; Komorowski J
    Mater Med Pol; 1980; 12(1-2):70-3. PubMed ID: 6799708
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acromegaly. I. Diagnostic use of radioimmunological determination of the somatotropic hormone].
    Marek J; Srámková J; Bleha O; Engelberth O
    Cas Lek Cesk; 1973; 112(24):745-50. PubMed ID: 4714502
    [No Abstract]   [Full Text] [Related]  

  • 14. [The clinical importance of growth hormone determinations in adults].
    Frey H; Norman N; Vogt JH
    Tidsskr Nor Laegeforen; 1968 Dec; 24():2258-65. PubMed ID: 4885895
    [No Abstract]   [Full Text] [Related]  

  • 15. [Permanent and non-suppressable somatotropic hypersecretion in acromegaly].
    Strauch G; Modigliani E; Bricaire H
    Presse Med (1893); 1970 Jan; 78(4):167-70. PubMed ID: 4907364
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly].
    Felt V; Nedvídková J
    Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating levels of myoglobin and muscle enzymes in acromegaly: effects of growth-hormone reduction by therapy.
    Giampietro O; Clerico A; Del Chicca MG; Masoni A; Buzzigoli G; Boni C; Navalesi R
    J Nucl Med Allied Sci; 1984; 28(4):263-70. PubMed ID: 6535833
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of parlodel on carbohydrate metabolism regulation in acromegaly].
    Molitvoslovova NN
    Sov Med; 1984; (1):24-9. PubMed ID: 6701649
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of somatotropin secretion in subjects with acromegaly].
    Giordano G; Marugo M; Minuto F; Barreca T
    Arch Maragliano Patol Clin; 1971; 27(5):257-91. PubMed ID: 5172811
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic value of hGH glucose suppression test in acromegaly (author's transl)].
    Deng JY
    Zhonghua Nei Ke Za Zhi; 1981 Aug; 20(8):467-70. PubMed ID: 7338080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.